0
Inquiry Basket

There is no product in the shopping cart, buy it!

GlycoErase™ B4GALT7 Knockout Jurkat Cell Line (CAT#: GLJF-0425-JF1279)

Datasheet
SizeQtyAdd To Basket
2 M cells/vial*2

Description B4GALT7 knockout Jurkat cell line lacks B4GALT7 protein, beta-1,4-galactosyltransferase 7, a member of beta4GalT family with diverse glycosylation functions. B4GALT7 knockout in Jurkat cells allows investigation of glycoconjugate biosynthesis disruption in T-cell leukemia, potentially affecting diverse beta-1,4-galactosyltransferase dependent glycosylation pathways and broadly impacting glycosylation-related processes in tumor cells due to beta4GalT family disruption.
Product Type KO Cell Lines
Species Human
Cell Morphology Suspension-growing
Passage Ratio 1:3~1:5
Cell Line Jurkat cell line
Primary Disease T-cell acute lymphoblastic leukemia (T-ALL)
Lineage T Lymphocyte
Lineage Subtype T-cell acute lymphoblastic leukemia (T-ALL)
Cell Viability >90%
Sterility Test The sterility test indicated an absence of microbial growth.
Identity Test STR identification
Mycoplasma Test Negative
Virus Test Negative for HIV, HBV and HCV.
Genetic Stability Testing We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements.
Validation PCR, Sanger Sequencing
Culture Medium FBS & Penicillin/Streptomycin & RPMI
Application Functional assay
Size 2 M cells/vial*2
Product Format Frozen
Shipping Dry ice
Availability Status Made to order
Handling Notes Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to.
Product Disclaimer This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous.
Target B4GALT7
Full Name Beta-1,4-galactosyltransferase 7
Alternative Name beta4Gal-T7, XGALT-1
Location 5q35.3
Gene ID 11285
Summary Beta-1,4-galactosyltransferase with exclusive specificity for UDP-galactose; involved in the biosynthesis of various glycoconjugates and saccharide structures.
For Research Use Only.
Online Inquiry
Creative Biolabs-Glycoprotein Follow us on
Close
Thanksgiving
Thanksgiving